SEARCH

SEARCH BY CITATION

Keywords:

  • alkenes;
  • cycloaddition;
  • labelling;
  • medicinal chemistry;
  • radiopharmacy;
  • technetium

Abstract

Reported herein is a new concept for the labelling of biomolecules with small [99mTcO3]+ complexes through a [3+2] cycloaddition with alkenes for radiopharmaceutical applications. We developed convenient reactions for the synthesis of small, water stable fac-[TcO3(tacn-R)]+ complexes (99Tc and 99mTc, tacn=1,4,7-triazacyclononane, R=H, -CH2-C6H5, -CH2-C6H4COOH). With alkenes, these high valent [99mTcO3]+ complexes undergo [3+2] cycloaddition with formation of the corresponding TcV–glycolato complexes. The 99mTcV and 99mTcVII complexes are stable at 37 °C in water and in the presence of serum proteins. Therefore, new opportunities in technetium chemistry are enabled with a high potential for medicinal and biological applications. In contrast to classical labelling, the presented strategy is ligand and not metal-centred.